Philips, N-of-One Team Up On Cancer Genomics
News Dec 06, 2016
Royal Philips and N-of-One, Inc. announced they are teaming up to enhance the capabilities of Philips’ IntelliSpace Genomics solution. The two companies will collaborate on the clinical analysis, annotation and interpretation of oncology cases processed through Philips new precision medicine solution for oncology. This healthcare informatics solution integrates genomic information with full patient context to empower clinicians with precision diagnostics and therapeutics, to enable them to measure the success of precision healthcare programs.
Profiling tumors using genomic information is critical for complex cancer cases, yet challenges remain in rapidly and accurately interpreting genomic findings in the context of a patient’s condition. While most cancer patients have thousands of gene variants and mutations, only a small number drive the individual’s specific cancer or may have actionable therapeutic implications for a particular patient.
The Philips IntelliSpace Genomics solution, which uniquely integrates complete patient information, is coupled with N-of-One’s rich experience and extensive knowledge-bases. For the first time, clinicians will have full access to N-of-One’s variant database during the case filtering and interpretation process, providing them ready access to the vast amount of available reference literature, guidelines, and evidence, in a fully interactive framework. The aim is to help clinicians determine which treatment options, clinical trials or medications, are best suited to a specific case.
Story from N-of-One. Please note: The content above may have been edited to ensure it is in keeping with Technology Networks’ style and length guidelines.
Molecules in Spit Could Help Diagnose ConcussionsNews
Diagnosing a concussion can sometimes be a guessing game, but clues taken from small molecules in saliva may be able to help diagnose and predict the duration of concussions in children, according to Penn State College of Medicine researchers.READ MORE
Breakthrough Discovery In Diagnostic Tools That Can Replace AntibodiesNews
Experts from the University of Leicester have announced the development of polymeric materials with molecular recognition capabilities which hold the potential to outperform natural antibodies in various diagnostic applications.READ MORE
Cell-weighing Method Could Help Doctors Choose Cancer DrugsNews
Researchers at MIT have now shown that they can use a new type of measurement to predict how drugs will affect cancer cells taken from multiple-myeloma patients.READ MORE